Achaogen Becomes First Biotech Tenant at Big South San Francisco Tower

Soon after she joined Achaogen Inc., Marisol Samperio was charged with a task that in the best of times is a tough one in the Bay Area: find a new home for the antibacterial drug developer.

These, however, are not normal times.

In the Peninsula real estate market, many cash-intensive biotech companies are competing for space against flashy, deep-pocketed tech companies, pushing lab-office lease rates close to $60 per square foot.

Back to news